Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

DVA

Delivra (DVA)

Delivra Corp
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:DVA
DateHeureSourceTitreSymboleSociété
03/07/201916h27PR Newswire (Canada)Harvest One Completes Acquisition of DelivraTSXV:DVADelivra Corp
28/06/201923h00PR Newswire (Canada)Harvest One and Delivra Provide Update on Closing Date of TransactionTSXV:DVADelivra Corp
31/05/201903h00PR Newswire (Canada)Delivra Announces Q1 2019 ResultsTSXV:DVADelivra Corp
28/05/201913h00PR Newswire (Canada)Delivra Corp. Announces Shareholder Approval of Plan of ArrangementTSXV:DVADelivra Corp
11/04/201913h00PR Newswire (Canada)Delivra Announces Record Sales For 2018TSXV:DVADelivra Corp
04/03/201915h08PR Newswire (Canada)Harvest One Acquires Delivra to Strengthen its Medical and Wellness DivisionTSXV:DVADelivra Corp
04/03/201915h06PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - DVATSXV:DVADelivra Corp
04/03/201915h04PR Newswire (Canada)IIROC Trading Resumption - DVATSXV:DVADelivra Corp
04/03/201914h37PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - DVATSXV:DVADelivra Corp
04/03/201914h34PR Newswire (Canada)IIROC Trading Halt - DVATSXV:DVADelivra Corp
06/02/201913h00PR Newswire (Canada)Delivra Publishes Positive Results Utilizing its Unique Platform Technology for Topical DoxycyclineTSXV:DVADelivra Corp
08/01/201913h00PR Newswire (Canada)Delivra publishes positive results utilizing its novel platform technology for Varicose VeinsTSXV:DVADelivra Corp
11/12/201813h00PR Newswire (Canada)Delivra publishes positive results using its platform technology for topical Advil™ (ibuprofen) and Celebrex™ (celecoxib)TSXV:DVADelivra Corp
27/11/201818h43PR Newswire (Canada)View from the C-Suite: Dr. Joseph Gabriele, Chief Executive Officer, Delivra Corp., tells his company's story. Filmed on Nove...TSXV:DVADelivra Corp
19/11/201813h00PR Newswire (Canada)Delivra Achieves Record Third Quarter 2018 RevenuesTSXV:DVADelivra Corp
30/10/201812h00PR Newswire (Canada)Ernst & Young Names Dr. Joseph Gabriele of Delivra - Entrepreneur of the Year 2018 Ontario Award in the Health Care CategoryTSXV:DVADelivra Corp
15/10/201813h00PR Newswire (Canada)Delivra Announces Stock Option Grant and Postponement of Warrant ExpiryTSXV:DVADelivra Corp
01/10/201813h00PR Newswire (Canada)Delivra Receiving Interest for its Expertise and Technology for Use in the Cannabis and Pharma IndustriesTSXV:DVADelivra Corp
27/08/201813h00PR Newswire (Canada)Delivra announces appointment of Chief Financial OfficerTSXV:DVADelivra Corp
20/08/201813h00PR Newswire (Canada)Delivra achieves record second quarter 2018 resultsTSXV:DVADelivra Corp
22/05/201813h00PR Newswire (Canada)Delivra Announces First Quarter Financial ResultsTSXV:DVADelivra Corp
03/05/201813h00PR Newswire (Canada)Delivra Exposes that the Cannabis Market Requires Further Standardization and Rigourous TestingTSXV:DVADelivra Corp
26/04/201813h00PR Newswire (Canada)Delivra's Successful Product Development Strategy Yields Product Line Expansions - Including Cannabis-Related ProductsTSXV:DVADelivra Corp
24/04/201813h00PR Newswire (Canada)Delivra successfully demonstrates targeted pain relief with topical ibuprofenTSXV:DVADelivra Corp
18/04/201813h00PR Newswire (Canada)Delivra Publishes Pivotal Results on the Cholesterol & Lipid Lowering Agent BerberineTSXV:DVADelivra Corp
10/04/201813h00PR Newswire (Canada)Delivra announces 20% sales growth for 2017TSXV:DVADelivra Corp
06/04/201801h09PR Newswire (Canada)Delivra Corp. Completes $1,246,498.20 Non-Brokered FinancingTSXV:DVADelivra Corp
01/02/201813h00PR Newswire (Canada)Delivra Signs Distribution Agreement With NKS Health for Ready to Market Compounded Finished Products to Medical DoctorsTSXV:DVADelivra Corp
25/01/201813h00PR Newswire (Canada)Delivra signs a joint venture with Intervivo Solutions for a ready to market sleep and anti-anxiety topical therapeutic cream...TSXV:DVADelivra Corp
16/01/201813h00PR Newswire (Canada)Delivra develops a revolutionary topical cream utilizing cannabis and opioid molecules for safer delivery in patients with ch...TSXV:DVADelivra Corp
 Showing the most relevant articles for your search:TSXV:DVA

Dernières Valeurs Consultées

Delayed Upgrade Clock